The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinicopathological features, efficacy of anti-EGFR therapy, and survival outcomes in patients with BRAF non-V600 mutated metastatic colorectal cancer.
 
Daisuke Kotani
Honoraria - Chugai Pharma; Merck Serono
 
Sebastián Mondaca
Travel, Accommodations, Expenses - Roche; Roche
 
Aparna Parikh
No Relationships to Disclose
 
Hideaki Bando
Research Funding - AstraZeneca; Sysmex
 
Emily Van Seventer
No Relationships to Disclose
 
Hiroya Taniguchi
Honoraria - Bayer; Chugai Pharma; Lilly Japan; Merck Serono; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Takayuki Yoshino
Research Funding - Chugai Pharma (Inst); GlaxoSmithKline (Inst); Sanofi (Inst); Sumitomo Dainippon (Inst)
 
Ryan Bruce Corcoran
Consulting or Advisory Role - Amgen; Astex Pharmaceuticals; Avidity Nanomedicines; Bristol-Myers Squibb; FOGPharma; Genentech; Loxo; Merrimack; N-of-One; Roche; Roivant; Shire; Spectrum Pharmaceuticals; Symphogen; Taiho Pharmaceutical; Warp Drive Bio
Research Funding - AstraZeneca; Sanofi
 
Rona Yaeger
Research Funding - Array BioPharma; GlaxoSmithKline; Novartis
Travel, Accommodations, Expenses - Array BioPharma
 
Hiromichi Ebi
Honoraria - AstraZeneca; Taiho Pharmaceutical
Consulting or Advisory Role - Lilly; Merck Serono